Dialectic Therapeutics, Inc. — Form D
Dialectic Therapeutics, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-29. The offering totals $5.0M, of which $2.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-12-29
- Form: D
- Accession: 0001750926-20-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.9M
- Remaining: $2.1M
- Minimum investment: $75K
- Investors: 12
- Date of first sale: 2020-12-15
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-384660
Issuer
- Name: Dialectic Therapeutics, Inc.
- CIK: 0001750926
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 12200 N STEMMONS FREEWAY, DALLAS, TX, 75234
- Phone: 9728888179
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| David Genecov | Director | San Jose, CA |
| David Genecov | Executive Officer | San Jose, CA |
| Daohong Zhou | Director | Dallas, TX |
| Daohong Zhou | Executive Officer | Dallas, TX |
| Joshua D Sills | Executive Officer | Dallas, TX |
| Robert Hromas | Director | Dallas, TX |
| Robert Hromas | Executive Officer | Dallas, TX |
| John D Harkey | Director | Dallas, TX |
Other filings by this issuer (3)
More